Introduction Adductor spasmodic dysphonia is an extremely disabling voice disorder that
negatively impacts a patient's quality of life (QOL). We performed a systematic review to …

Adductory spasmodic dysphonia is a focal dystonia of laryngeal muscles. Patients with this
disorder typically have severe vocal difficulties, with significant functional, social, and …

Objective The effect of botulinum toxin among patients with adductor spasmodic dysphonia
(AdSD) is temporary. To optimize long-term treatment outcome, other therapy options should …

Objective To investigate the longitudinal effects of botulinum toxin type A (Botox) injections
on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia …

Objective: Botulinum toxin (BT) injection improves objective and subjective voice
measurements in spasmodic dysphonia; however, it is not clear whether the results are …

Background Botulinum toxin A (BT) is the gold standard treatment for adductor spasmodic
dysphonia (AdSD) with established use for greater than thirty years. The spasmodic …

Objective: Botulinum toxin injections are used routinely to treat patients with adductor
spasmodic dysphonia. After an initial “breathy phase,” most patients experience …

To determine the effectiveness of Botox treatment for adductor spasmodic dysphonia
(ADSD), the clinician and patient judge changes in voice symptoms and the effect on quality …

Background: Botulinum toxin injection under electromyographic guidance is the 'gold
standard'for adductor spasmodic dysphonia treatment. The point-touch technique, an …

Objective To review vocal outcome measures, using the Voice Related Quality of Life
(VRQOL) index, after simultaneous bilateral posterior cricoarytenoid muscle botulinum toxin …